The top news stories from Latin America

Provided by AGP

Got News to Share?

Latin American Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin American Newswire.

Press releases published on March 23, 2026

BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair
BingX Futures Trading 2.0: Powering the Next Era of Trading 
FEMSA Completes Accelerated Share Repurchase Agreement, and Announces New Agreement
FEMSA finaliza Acuerdo de Recompra Acelerada de Acciones, y anuncia nuevo Acuerdo
Critical Metals Corp. Nasdaq-CRML Announces the Successful Acquisition of the Leading Turn-Key Engineering, Mining, Construction, Infrastructure & Drilling Operator Within Greenland (60 Degree North Greenland A/S)
Biodexa Launches Global Early Access Program for eRapa for FAP Patients  Through Strategic Partnership with Tanner Pharma Group
NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update
Onconetix, Inc. Announces 1-for-5 Reverse Stock Split
RenovoRx Announces Closing of Oversubscribed $10 Million at Market Private Placement
HomePro Publica el Índice de Costos de Mantenimiento de Marzo 2026 para Empresas en la Ciudad de México
NÖK Therapeutics to Present Long-Term Clinical Data at the 11th Annual Innate Killer Summit
Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors
Terra Balcanica Announces Private Placement Financing
Sapu Nano to Present Everolimus Toxicology Data at SOT 2026 Annual Meeting
ORYZON Announces U.S. Patent Grant Covering Iadademstat Combinations with Venetoclax
Tempest Therapeutics Announces Up To $6 Million Private Placement
Nano Labs to Announce Second Half of Fiscal Year 2025 Financial Results on March 30, 2026
Quality Longevity Company Enlivex Receives Investigational New Drug (IND) Clearance from the FDA for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
BridgeBio to Present Long-Term Efficacy and Safety Data from the ATTRibute-CM OLE Trial at the ACC Annual Scientific Sessions
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Share us

on your social networks:

Sign up for:

Latin American Newswire

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.